Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$-151.37 Mln
EBITDA
$-166.68 Mln
Net Profit
$-147.72 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
XOMA Corporation (XOMAP)
| -7.0 | -1.8 | -4.4 | -2.5 | 0.4 | -1.1 | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
XOMA Corporation (XOMAP)
| 3.8 | 1.8 | 2.5 | -5.7 | 5.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout XOMA Corporation (XOMAP)
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial... products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated. Read more
-
CEO & Director
Mr. Owen P. Hughes Jr.
-
CEO & Director
Mr. Owen P. Hughes Jr.
-
Headquarters
EmeryVille, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for XOMA Corporation (XOMAP)
What is the current share price of XOMA Corporation (XOMAP) Today?
The share price of XOMA Corporation (XOMAP) is $24.98 (NASDAQ) as of 21-Jul-2026 09:30 EDT. XOMA Corporation (XOMAP) has given a return of 0.38% in the last 3 years.
What is the current PB & PE ratio of XOMA Corporation (XOMAP)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
15.33 |
4.68 |
2024 |
-22.19 |
3.74 |
2023 |
-7.14 |
3.29 |
2022 |
-16.61 |
2.29 |
2021 |
18.86 |
2.10 |
What is the 52 Week High and Low of XOMA Corporation (XOMAP)?
The 52-week high and low of XOMA Corporation (XOMAP) are Rs 29.26 and Rs 24.93 as of 05-Sep-2026.
What is the market cap of XOMA Corporation (XOMAP)?
XOMA Corporation (XOMAP) has a market capitalisation of -- as on 21-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in XOMA Corporation (XOMAP)?
Before investing in XOMA Corporation (XOMAP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.